Pacira BioSciences Inc

+1.35 (+1.95%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.09B
Current PE21.26
Forward PE 20.75
2yr Forward PE 16.56
See more stats
Estimates Current Quarter
Revenue$118.6 Million
Adjusted EPS$0.63
See more estimates
10-Day MA$71.42
50-Day MA$70.14
200-Day MA$59.49
See more pivots

Pacira Biosciences, Inc. Stock, NASDAQ:PCRX

5 Sylvan Way, Suite 300, Parsippany, New Jersey 07054
Phone: +1.973.254.3560
Number of Employees: 606


Pacira Biosciences, Inc. develops and manufactures injectable therapeutic products. The firm engages in the development, commercialization and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ.